Education
About Us
Working with TipRanks
Follow Us
Lisa Earnhardt Insider Profile
4 Followers
Lisa Earnhardt, Director at Intersect ENT, holds 71.93K shares in Abbott Laboratories (Ticker: ABT), holds 379.37K shares in Intersect ENT (Ticker: XENT), holds 5.30K shares in Nevro Corp (Ticker: NVRO).
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-16.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lisa Earnhardt holds in companies
Most Profitable Insider Trade
The most profitable trade made by Lisa Earnhardt
Lisa Earnhardt's Trading History
Intersect ENT
Jan 18, 2019
―
Uninformative Buy
―
$10.71M
Abbott Laboratories
Mar 07, 2025
EVP AND GROUP PRESIDENT
Uninformative Buy
7.40M
$9.86M
Nevro Corp
May 23, 2018
Director
Uninformative Buy
―
$30.60K
List of latest transactions for each holding click on a transaction to see Lisa Earnhardt's performance on stock
You May Also Like
Lisa Earnhardt insider profile FAQ
What is the percentage of profitable transactions made by Lisa Earnhardt?
The percentage of profitable transactions made by Lisa Earnhardt is 0%.
What is the average return per transaction made by Lisa Earnhardt?
The average return per transaction made by Lisa Earnhardt is -16.50%.
What stocks does Lisa Earnhardt hold?
Lisa Earnhardt holds: XENT, ABT, NVRO stocks.
What was Lisa Earnhardt’s latest transaction?
Lisa Earnhardt latest transaction was an Uninformative Buy of $7.40M.
What was Lisa Earnhardt's most profitable transaction?
Lisa Earnhardt’s most profitable transaction was an Informative Sell of ABT stock on March 7, 2025. The return on the trade was 0.00%.
What is Lisa Earnhardt's role in Intersect ENT?
Lisa Earnhardt's role in Intersect ENT is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.